acetazolamide has been researched along with Glaucoma, Suspect in 69 studies
Acetazolamide: One of the CARBONIC ANHYDRASE INHIBITORS that is sometimes effective against absence seizures. It is sometimes useful also as an adjunct in the treatment of tonic-clonic, myoclonic, and atonic seizures, particularly in women whose seizures occur or are exacerbated at specific times in the menstrual cycle. However, its usefulness is transient often because of rapid development of tolerance. Its antiepileptic effect may be due to its inhibitory effect on brain carbonic anhydrase, which leads to an increased transneuronal chloride gradient, increased chloride current, and increased inhibition. (From Smith and Reynard, Textbook of Pharmacology, 1991, p337)
| Excerpt | Relevance | Reference |
|---|---|---|
| "To examine whether intraocular pressure (IOP) increases immediately after cataract surgery in eyes with pseudoexfoliation (PXF) syndrome and to assess whether orally administered acetazolamide can prevent the IOP elevation." | 9.27 | Intraocular pressure elevation after cataract surgery and its prevention by oral acetazolamide in eyes with pseudoexfoliation syndrome. ( Hayashi, K; Manabe, SI; Sato, T; Yoshida, M; Yoshimura, K, 2018) |
| "To confirm the prophylactic effect of oral acetazolamide against increased intraocular pressure (IOP) in the period immediately after cataract surgery in eyes with primary open-angle glaucoma (POAG) and to evaluate the appropriate administration time of oral acetazolamide to prevent IOP elevation." | 9.24 | Prophylactic Effect of Oral Acetazolamide against Intraocular Pressure Elevation after Cataract Surgery in Eyes with Glaucoma. ( Hayashi, K; Manabe, SI; Yoshida, M; Yoshimura, K, 2017) |
| "To demonstrate that preoperative treatment for 28 days with topical dorzolamide/timolol is non-inferior (Δ = 4 mm Hg) to oral acetazolamide and topical dexamethasone (standard therapy) in terms of intraocular pressure (IOP) reduction 3 and 6 months after trabeculectomy in glaucoma patients." | 9.24 | Efficacy and safety of preoperative IOP reduction using a preservative-free fixed combination of dorzolamide/timolol eye drops versus oral acetazolamide and dexamethasone eye drops and assessment of the clinical outcome of trabeculectomy in glaucoma. ( Bell, K; Keicher, A; Lorenz, K; Pfeiffer, N; Renieri, G; Ruckes, C; Thieme, H; Wasielica-Poslednik, J, 2017) |
| "To determine the effect of oral acetazolamide on lowering the peak and duration of intraocular pressure (IOP) rise in glaucoma and glaucoma suspect patients, following intravitreal injection of ranibizumab for neovascular age-related macular degeneration." | 9.19 | Short-term intraocular pressure trends following intravitreal ranibizumab injections for neovascular age-related macular degeneration-the role of oral acetazolamide in protecting glaucoma patients. ( Allgar, V; Gale, RP; Murray, CD; Walters, G; Wood, D, 2014) |
| "To evaluate the effects of oral acetazolamide (ACZ), anterior chamber paracentesis (ACP), or topical brimonidine tartrate (BT) to reduce intraocular pressure (IOP) elevation after intravitreal bevacizumab injection (IVBI)." | 9.19 | Comparison of acetazolamide, brimonidine, and anterior chamber paracentesis for ocular hypertension control after initial intravitreal bevacizumab injection: a randomized clinical trial. ( Bonini-Filho, MA; Costa, R; Jorge, R; Katayama, BY; Martin, LF; Messias, AM; Paula, JS, 2014) |
| "To assess the effect of intraoperative acetazolamide (Diamox) on postoperative intraocular pressure (IOP) in gas-filled, vitrectomized eyes." | 9.09 | Intraoperative acetazolamide in the prevention of intraocular pressure rise after pars plana vitrectomy with fluid-gas exchange. ( Grand, MG; Ruby, AJ; Thomas, MA; Williams, D, 1999) |
| "The aim of this study was to evaluate the effectiveness of topical dorzolamide versus systemic acetazolamide in preventing the intraocular pressure (IOP) spike, following routine phacoemulsification surgery." | 9.08 | A comparison of the effectiveness of dorzolamide and acetazolamide in preventing post-operative intraocular pressure rise following phacoemulsification surgery. ( Lukaris, A; Roberts-Harry, TJ; Rogers, ZA; Sells, M; Zohdy, GA, 1998) |
| "The study aimed to determine whether topical dorzolamide and systemic acetazolamide have an additive effect on intraocular pressure (IOP) and aqueous humor formation (AHF)." | 9.08 | Combination of systemic acetazolamide and topical dorzolamide in reducing intraocular pressure and aqueous humor formation. ( Hong, PH; Krupin, T; Rosenberg, LF; Ruderman, JM; Tang, LQ, 1998) |
| "To compare postoperative intraocular pressure (IOP) after administration of acetazolamide and timolol following phacoemulsification and intraocular lens implantation." | 9.08 | Timolol gel versus acetazolamide in the prophylaxis of ocular hypertension after phacoemulsification. ( Donnenfeld, ED; Kanellopoulos, AJ; Perry, HD, 1997) |
| "0% dorzolamide hydrochloride with oral acetazolamide in preventing intraocular pressure (IOP) rise following neodymium:YAG (Nd:YAG) laser posterior capsulotomy." | 9.08 | Topical 2.0% dorzolamide vs oral acetazolamide for prevention of intraocular pressure rise after neodymium:YAG laser posterior capsulotomy. ( Baltatzis, S; Kokolakis, SN; Ladas, ID; Panagiotidis, D; Theodossiadis, GP; Zafirakis, P, 1997) |
| "To investigate the additive ocular hypotensive effect of latanoprost on the intraocular pressure (IOP) reduction induced by a suboptimal dose of acetazolamide, a carbonic anhydrase inhibitor." | 9.08 | Additive ocular hypotensive effect of latanoprost and acetazolamide. A short-term study in patients with elevated intraocular pressure. ( Greve, EL; Hoyng, PF; Rulo, AH, 1997) |
| "Prophylactic use of timolol gel for viscoelastic-induced ocular hypertension after PK appears to offer better IOP control than oral acetazolamide, with potentially fewer adverse systemic effects." | 9.08 | Comparison of topical timolol gel to oral acetazolamide in the prophylaxis of viscoelastic-induced ocular hypertension after penetrating keratoplasty. ( Donnenfeld, ED; Kanellopoulos, AJ; Perry, HD, 1997) |
| "This prospective study was done to compare the efficacy of timolol and acetazolamide in lowering the intraocular pressure (IOP) secondary to the use of sodium hyaluronate (Healon) in cataract surgery." | 9.07 | Effect of timolol vs. acetazolamide on sodium hyaluronate-induced rise in intraocular pressure after cataract surgery. ( Duperré, J; Grenier, B; Lambert, J; Lemire, J; Mihalovits, H; Sebag, M, 1994) |
| "Acetazolamide was capable of preventing the excessive IOP rise during dialysis." | 5.28 | Intraocular pressure changes during hemodialysis: prevention of excessive dialytic rise and development of severe metabolic acidosis following acetazolamide therapy. ( Cecchin, E; De Marchi, S; Tesio, F, 1989) |
| "To examine whether intraocular pressure (IOP) increases immediately after cataract surgery in eyes with pseudoexfoliation (PXF) syndrome and to assess whether orally administered acetazolamide can prevent the IOP elevation." | 5.27 | Intraocular pressure elevation after cataract surgery and its prevention by oral acetazolamide in eyes with pseudoexfoliation syndrome. ( Hayashi, K; Manabe, SI; Sato, T; Yoshida, M; Yoshimura, K, 2018) |
| "To confirm the prophylactic effect of oral acetazolamide against increased intraocular pressure (IOP) in the period immediately after cataract surgery in eyes with primary open-angle glaucoma (POAG) and to evaluate the appropriate administration time of oral acetazolamide to prevent IOP elevation." | 5.24 | Prophylactic Effect of Oral Acetazolamide against Intraocular Pressure Elevation after Cataract Surgery in Eyes with Glaucoma. ( Hayashi, K; Manabe, SI; Yoshida, M; Yoshimura, K, 2017) |
| "To demonstrate that preoperative treatment for 28 days with topical dorzolamide/timolol is non-inferior (Δ = 4 mm Hg) to oral acetazolamide and topical dexamethasone (standard therapy) in terms of intraocular pressure (IOP) reduction 3 and 6 months after trabeculectomy in glaucoma patients." | 5.24 | Efficacy and safety of preoperative IOP reduction using a preservative-free fixed combination of dorzolamide/timolol eye drops versus oral acetazolamide and dexamethasone eye drops and assessment of the clinical outcome of trabeculectomy in glaucoma. ( Bell, K; Keicher, A; Lorenz, K; Pfeiffer, N; Renieri, G; Ruckes, C; Thieme, H; Wasielica-Poslednik, J, 2017) |
| "To evaluate the effects of oral acetazolamide (ACZ), anterior chamber paracentesis (ACP), or topical brimonidine tartrate (BT) to reduce intraocular pressure (IOP) elevation after intravitreal bevacizumab injection (IVBI)." | 5.19 | Comparison of acetazolamide, brimonidine, and anterior chamber paracentesis for ocular hypertension control after initial intravitreal bevacizumab injection: a randomized clinical trial. ( Bonini-Filho, MA; Costa, R; Jorge, R; Katayama, BY; Martin, LF; Messias, AM; Paula, JS, 2014) |
| "To determine the effect of oral acetazolamide on lowering the peak and duration of intraocular pressure (IOP) rise in glaucoma and glaucoma suspect patients, following intravitreal injection of ranibizumab for neovascular age-related macular degeneration." | 5.19 | Short-term intraocular pressure trends following intravitreal ranibizumab injections for neovascular age-related macular degeneration-the role of oral acetazolamide in protecting glaucoma patients. ( Allgar, V; Gale, RP; Murray, CD; Walters, G; Wood, D, 2014) |
| "05 mL of bevacizumab or ranibizumab), that were divided into five groups, group 1: no intraocular pressure (IOP)-lowering medication (n=50); group 2: apraclonidine 1 % one drop 2 hours prior to IVI (n=50); group 3: acetazolamide 250 mg 2 hours prior (n=50); group 4: fixed combination brimonidine+timolol (n=30); group 5: fixed combination dorzolamide+timolol (n=30)." | 5.16 | [Efficacy of prophylactic treatment of intraocular pressure spikes due to intravitreal injections]. ( Dot, C; El Chehab, H; Giraud, JM; Le Corre, A; Ract-Madoux, G; Swalduz, B, 2012) |
| "5% in preventing intraocular pressure (IOP) peaks during the early period after phacoemulsification in which sodium chondroitin sulfate 4%-sodium hyaluronate 3% (Viscoat) was used as the ophthalmic viscosurgical device (OVD)." | 5.12 | Effect of antiglaucoma agents on postoperative intraocular pressure after cataract surgery with Viscoat. ( Akman, A; Akova, YA; Borazan, M; Karalezli, A, 2007) |
| "In 30 patients with ocular hypertension, aqueous flow and intraocular pressure (IOP) were determined at baseline and on the following combinations of drugs in a crossover design: (1) vehicle alone, (2) dorzolamide alone, (3) acetazolamide alone, (4) timolol alone, (5) dorzolamide + acetazolamide, and (6) dorzolamide + timolol." | 5.11 | Effects on aqueous flow of dorzolamide combined with either timolol or acetazolamide. ( Camras, CB; Toris, CB; Yablonski, ME; Zhan, GL, 2004) |
| "To assess the effect of intraoperative acetazolamide (Diamox) on postoperative intraocular pressure (IOP) in gas-filled, vitrectomized eyes." | 5.09 | Intraoperative acetazolamide in the prevention of intraocular pressure rise after pars plana vitrectomy with fluid-gas exchange. ( Grand, MG; Ruby, AJ; Thomas, MA; Williams, D, 1999) |
| "Prophylactic use of timolol gel for viscoelastic-induced ocular hypertension after PK appears to offer better IOP control than oral acetazolamide, with potentially fewer adverse systemic effects." | 5.08 | Comparison of topical timolol gel to oral acetazolamide in the prophylaxis of viscoelastic-induced ocular hypertension after penetrating keratoplasty. ( Donnenfeld, ED; Kanellopoulos, AJ; Perry, HD, 1997) |
| "0% dorzolamide hydrochloride with oral acetazolamide in preventing intraocular pressure (IOP) rise following neodymium:YAG (Nd:YAG) laser posterior capsulotomy." | 5.08 | Topical 2.0% dorzolamide vs oral acetazolamide for prevention of intraocular pressure rise after neodymium:YAG laser posterior capsulotomy. ( Baltatzis, S; Kokolakis, SN; Ladas, ID; Panagiotidis, D; Theodossiadis, GP; Zafirakis, P, 1997) |
| "To compare postoperative intraocular pressure (IOP) after administration of acetazolamide and timolol following phacoemulsification and intraocular lens implantation." | 5.08 | Timolol gel versus acetazolamide in the prophylaxis of ocular hypertension after phacoemulsification. ( Donnenfeld, ED; Kanellopoulos, AJ; Perry, HD, 1997) |
| "The study aimed to determine whether topical dorzolamide and systemic acetazolamide have an additive effect on intraocular pressure (IOP) and aqueous humor formation (AHF)." | 5.08 | Combination of systemic acetazolamide and topical dorzolamide in reducing intraocular pressure and aqueous humor formation. ( Hong, PH; Krupin, T; Rosenberg, LF; Ruderman, JM; Tang, LQ, 1998) |
| "The aim of this study was to evaluate the effectiveness of topical dorzolamide versus systemic acetazolamide in preventing the intraocular pressure (IOP) spike, following routine phacoemulsification surgery." | 5.08 | A comparison of the effectiveness of dorzolamide and acetazolamide in preventing post-operative intraocular pressure rise following phacoemulsification surgery. ( Lukaris, A; Roberts-Harry, TJ; Rogers, ZA; Sells, M; Zohdy, GA, 1998) |
| "Following a timolol and acetazolamide run-in, 105 patients with elevated intraocular pressure (IOP) were randomized to dorzolamide or acetazolamide, in addition to timolol, for 12 weeks." | 5.08 | A comparison of the efficacy and tolerability of dorzolamide and acetazolamide as adjunctive therapy to timolol. Oral to Topical CAI Study Group. ( Adamsons, IA; Hutzelmann, JE; Michael, AJ; Polis, AB, 1998) |
| "To investigate the additive ocular hypotensive effect of latanoprost on the intraocular pressure (IOP) reduction induced by a suboptimal dose of acetazolamide, a carbonic anhydrase inhibitor." | 5.08 | Additive ocular hypotensive effect of latanoprost and acetazolamide. A short-term study in patients with elevated intraocular pressure. ( Greve, EL; Hoyng, PF; Rulo, AH, 1997) |
| "This prospective study was done to compare the efficacy of timolol and acetazolamide in lowering the intraocular pressure (IOP) secondary to the use of sodium hyaluronate (Healon) in cataract surgery." | 5.07 | Effect of timolol vs. acetazolamide on sodium hyaluronate-induced rise in intraocular pressure after cataract surgery. ( Duperré, J; Grenier, B; Lambert, J; Lemire, J; Mihalovits, H; Sebag, M, 1994) |
| "The IOP 1-day postoperatively was analysed against the last recorded IOP before phacoemulsification in a cohort of patients with glaucoma or OHT who underwent uncomplicated phacoemulsification cataract surgery between December 2009 and September 2012, where it was routine practice to give acetazolamide postoperatively." | 3.81 | Is the 1-day postoperative IOP check needed post uncomplicated phacoemulsification in patients with glaucoma and ocular hypertension? ( Gupta, A; Vernon, SA, 2015) |
| "To present the case of a 28-year-old man with acetazolamide-induced bilateral choroidal effusion after uneventful surgery of the second eye in delayed sequential bilateral insertion of an implantable collamer lens for hyperopia." | 3.79 | Acetazolamide-induced bilateral choroidal effusion following insertion of a phakic implantable collamer lens. ( Baviera, J; de Rojas, V; González-López, F, 2013) |
| " The use of systemic acetazolamide provided significant control of IOP and could be considered a 'possible standard' management of cataract surgery in POAG patients." | 3.78 | Short-term changes in intraocular pressure after phacoemulsification in glaucoma patients. ( Centofanti, M; Digiuni, M; Fea, A; Figus, M; Fogagnolo, P; Frezzotti, P; Lembo, A; Ligorio, P; Lorenzi, U; Rossetti, L, 2012) |
| " In an animal model of ocular hypertension, one of the new compounds was twice more effective than dorzolamide in reducing elevated intraocular pressure characteristic of this disease, anticipating their potential for the treatment of glaucoma." | 3.77 | Synthesis and crystallographic analysis of new sulfonamides incorporating NO-donating moieties with potent antiglaucoma action. ( Benedini, F; Biondi, S; Cecchi, A; Formicola, G; Masini, E; Mincione, F; Pacileo, I; Scozzafava, A; Supuran, CT; Temperini, C, 2011) |
| "Acetazolamide's usefulness in the treatment of the glaucomas is limited by the systemic side effects that often accompany its oral administration, and topical administration was initially thought to have no effect upon the intraocular pressures of human and rabbit eyes." | 3.67 | Local ocular hypotensive effect of topically applied acetazolamide. ( Flach, AJ; Peterson, JS; Seligmann, KA, 1984) |
| "A patient with ocular hypertension was treated with acetazolamide." | 3.67 | Tamm-Horsfall protein accumulation in glomeruli during acetazolamide-induced acute renal failure. ( Jondeau, G; Kanfer, A; Mougenot, B; Ronco, P; Rondeau, E; Rossert, J; Sraer, JD, 1989) |
| "Intraocular pressure was measured preoperatively and 4 to 6 and 24 hours postoperatively." | 2.69 | Medical control of intraocular pressure after cataract surgery. ( Byrd, S; Singh, K, 1998) |
| "Rapid progression was observed from ocular hypertension to uveitic glaucoma." | 1.72 | High rate of conversion from ocular hypertension to glaucoma in subjects with uveitis. ( Bennett, S; Chew, S; Ma, T; Niederer, RL; Sims, JL, 2022) |
| "Iris metastases were treated with 40 Gray of radiation therapy and concurrent chemotherapy." | 1.62 | Iris metastasis as the initial presentation of metastatic esophageal cancer diagnosed by fine needle aspiration biopsy: A case report. ( Horiuchi, N; Kuribayashi, T; Kurihara, T; Ozawa, H; Smith, LEH; Takano, Y; Tomita, Y; Tsubota, K; Usui, Y, 2021) |
| "Eight monkeys with untreated intraocular pressures (IOPs) of less than 18 mmHg in one eye (ONT group) and seven with untreated IOPs of greater than or equal to 18 mmHg in one eye (OHT group) were included in the study." | 1.36 | Aqueous humor dynamics in inbred rhesus monkeys with naturally occurring ocular hypertension. ( Dawson, WW; Gonzales-Martinez, J; McLaughlin, MA; Risma, JM; Toris, CB, 2010) |
| "Fifty-four eyes of 45 patients with ocular hypertension developed early glaucomatous optic disc or visual field changes after a mean follow-up of 5." | 1.29 | Visual field prognosis in early glaucoma. A long-term clinical follow-up. ( Odberg, T, 1993) |
| "Such an agent would be useful in the treatment of glaucoma." | 1.28 | Topically active carbonic anhydrase inhibitors. 2. Benzo[b]thiophenesulfonamide derivatives with ocular hypotensive activity. ( Anderson, PS; Baldwin, JJ; Best, DB; Christy, ME; Freedman, MB; Gautheron, P; Graham, SL; Habecker, CN; Hoffman, JM; Shepard, KL, 1989) |
| "The ischemia was induced by elevating intraocular pressure; retinal and RPE function were monitored by electrophysiologic recordings." | 1.28 | Recovery of retinal pigment epithelial function after ischemia in the rabbit. ( Heike, M; Marmor, MF, 1991) |
| "Acetazolamide was capable of preventing the excessive IOP rise during dialysis." | 1.28 | Intraocular pressure changes during hemodialysis: prevention of excessive dialytic rise and development of severe metabolic acidosis following acetazolamide therapy. ( Cecchin, E; De Marchi, S; Tesio, F, 1989) |
| "Methylcellulose has been used since 1976 to prevent damage to the corneal endothelium during operations for implantation of intraocular lenses." | 1.27 | Methylcellulose, a viscous cushioning material in ophthalmic surgery. ( Fechner, PU, 1983) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (14.49) | 18.7374 |
| 1990's | 24 (34.78) | 18.2507 |
| 2000's | 13 (18.84) | 29.6817 |
| 2010's | 20 (28.99) | 24.3611 |
| 2020's | 2 (2.90) | 2.80 |
| Authors | Studies |
|---|---|
| Graham, SL | 1 |
| Shepard, KL | 1 |
| Anderson, PS | 1 |
| Baldwin, JJ | 1 |
| Best, DB | 1 |
| Christy, ME | 1 |
| Freedman, MB | 1 |
| Gautheron, P | 1 |
| Habecker, CN | 1 |
| Hoffman, JM | 1 |
| Mincione, F | 1 |
| Benedini, F | 1 |
| Biondi, S | 1 |
| Cecchi, A | 1 |
| Temperini, C | 1 |
| Formicola, G | 1 |
| Pacileo, I | 1 |
| Scozzafava, A | 2 |
| Masini, E | 2 |
| Supuran, CT | 2 |
| Ferraroni, M | 1 |
| Lucarini, L | 1 |
| Korsakov, M | 1 |
| Krasavin, M | 1 |
| Ma, T | 1 |
| Sims, JL | 1 |
| Bennett, S | 1 |
| Chew, S | 1 |
| Niederer, RL | 1 |
| Ozawa, H | 1 |
| Usui, Y | 1 |
| Takano, Y | 1 |
| Horiuchi, N | 1 |
| Kuribayashi, T | 1 |
| Kurihara, T | 1 |
| Smith, LEH | 1 |
| Tsubota, K | 1 |
| Tomita, Y | 1 |
| Hayashi, K | 2 |
| Yoshida, M | 2 |
| Sato, T | 1 |
| Manabe, SI | 2 |
| Yoshimura, K | 2 |
| Babiker, S | 1 |
| Elsayed, ME | 1 |
| Dhaygude, A | 1 |
| Madgula, I | 1 |
| Katayama, BY | 1 |
| Bonini-Filho, MA | 1 |
| Messias, AM | 1 |
| Paula, JS | 1 |
| Martin, LF | 1 |
| Costa, R | 1 |
| Jorge, R | 1 |
| de Rojas, V | 1 |
| González-López, F | 1 |
| Baviera, J | 1 |
| Karaśkiewicz, J | 1 |
| Lubiński, W | 1 |
| Penkala, K | 1 |
| Gharbiya, M | 1 |
| Colica, C | 1 |
| Campagna, O | 1 |
| De Vico, U | 1 |
| Cruciani, F | 1 |
| Murray, CD | 1 |
| Wood, D | 1 |
| Allgar, V | 1 |
| Walters, G | 1 |
| Gale, RP | 1 |
| Gupta, A | 1 |
| Vernon, SA | 1 |
| Holtmann, C | 1 |
| Spaniol, K | 1 |
| Geerling, G | 1 |
| Dot, C | 2 |
| El Chehab, H | 2 |
| Russo, A | 1 |
| Agard, E | 1 |
| Unlu, M | 1 |
| Hondur, AM | 1 |
| Korkmaz, S | 1 |
| Kumova, D | 1 |
| Yuksel, E | 1 |
| Lorenz, K | 1 |
| Wasielica-Poslednik, J | 1 |
| Bell, K | 1 |
| Renieri, G | 1 |
| Keicher, A | 1 |
| Ruckes, C | 1 |
| Pfeiffer, N | 1 |
| Thieme, H | 1 |
| Li Yim, JF | 1 |
| Ross, JZ | 1 |
| Jay, JL | 1 |
| Toris, CB | 2 |
| Risma, JM | 1 |
| Gonzales-Martinez, J | 1 |
| McLaughlin, MA | 1 |
| Dawson, WW | 1 |
| Murakami, J | 1 |
| Kim, A | 1 |
| Sugiyama, T | 1 |
| Inoue, K | 1 |
| Matsumoto, C | 1 |
| Shimomura, Y | 1 |
| Fogagnolo, P | 1 |
| Centofanti, M | 1 |
| Figus, M | 1 |
| Frezzotti, P | 1 |
| Fea, A | 1 |
| Ligorio, P | 1 |
| Lembo, A | 1 |
| Digiuni, M | 1 |
| Lorenzi, U | 1 |
| Rossetti, L | 1 |
| Le Corre, A | 1 |
| Giraud, JM | 1 |
| Ract-Madoux, G | 1 |
| Swalduz, B | 1 |
| KLEINERT, H | 1 |
| RADOVANOVIC, M | 1 |
| YANKELEVICH, IJ | 1 |
| Zhan, GL | 1 |
| Yablonski, ME | 1 |
| Camras, CB | 1 |
| Viestenz, A | 1 |
| Martus, P | 2 |
| Schlötzer-Schrehardt, U | 1 |
| Langenbucher, A | 1 |
| Mardin, CY | 1 |
| Călugăru, M | 1 |
| Călugăru, D | 1 |
| Kurian, M | 1 |
| Shetty, R | 1 |
| Shetty, BK | 1 |
| Devi, SA | 1 |
| Scuderi, G | 1 |
| Regine, F | 1 |
| Perdicchi, A | 1 |
| Mannino, G | 1 |
| Recupero, SM | 1 |
| Dada, T | 1 |
| Muralidhar, R | 1 |
| Jhanji, V | 1 |
| Borazan, M | 1 |
| Karalezli, A | 1 |
| Akman, A | 1 |
| Akova, YA | 1 |
| Smith, JP | 1 |
| Weeks, RH | 1 |
| Newland, EF | 1 |
| Ward, RL | 1 |
| Fechner, PU | 1 |
| Flach, AJ | 1 |
| Peterson, JS | 1 |
| Seligmann, KA | 1 |
| Feist, RM | 1 |
| Palmer, DJ | 1 |
| Fiscella, R | 1 |
| Ernest, JT | 1 |
| Tripathi, R | 1 |
| Torczynski, E | 1 |
| Farber, M | 1 |
| John, M | 1 |
| Souchek, J | 1 |
| Noblitt, RL | 1 |
| Boleyn, KL | 1 |
| Davis, LC | 1 |
| Bömer, TG | 1 |
| Lagrèze, WD | 1 |
| Funk, J | 1 |
| Duperré, J | 1 |
| Grenier, B | 1 |
| Lemire, J | 1 |
| Mihalovits, H | 1 |
| Sebag, M | 1 |
| Lambert, J | 1 |
| Odberg, T | 1 |
| Ladas, ID | 2 |
| Pavlopoulos, GP | 1 |
| Kokolakis, SN | 2 |
| Theodossiadis, GP | 2 |
| Barak, A | 1 |
| Desatnik, H | 1 |
| Ma-Naim, T | 1 |
| Ashkenasi, I | 1 |
| Neufeld, A | 1 |
| Melamed, S | 1 |
| Edmunds, B | 1 |
| Canning, CR | 1 |
| Whitefield, L | 1 |
| Crowston, J | 1 |
| Little, BC | 1 |
| Kanellopoulos, AJ | 2 |
| Perry, HD | 2 |
| Donnenfeld, ED | 2 |
| Rulo, AH | 1 |
| Greve, EL | 1 |
| Hoyng, PF | 1 |
| Baltatzis, S | 1 |
| Panagiotidis, D | 1 |
| Zafirakis, P | 1 |
| Kondo, T | 1 |
| Miyazawa, D | 1 |
| Unigame, K | 1 |
| Kurimoto, Y | 1 |
| Rosenberg, LF | 1 |
| Krupin, T | 1 |
| Tang, LQ | 1 |
| Hong, PH | 1 |
| Ruderman, JM | 1 |
| Zohdy, GA | 1 |
| Rogers, ZA | 1 |
| Lukaris, A | 1 |
| Sells, M | 1 |
| Roberts-Harry, TJ | 1 |
| Byrd, S | 1 |
| Singh, K | 1 |
| Hutzelmann, JE | 1 |
| Polis, AB | 1 |
| Michael, AJ | 1 |
| Adamsons, IA | 1 |
| Fichman, RA | 1 |
| Ruby, AJ | 1 |
| Grand, MG | 1 |
| Williams, D | 1 |
| Thomas, MA | 1 |
| Chakraborty, P | 1 |
| Villada, JR | 1 |
| Tinu, A | 1 |
| Ogawa, T | 1 |
| Kitaoka, T | 1 |
| Mera, A | 1 |
| Saitoh, AK | 1 |
| Amemiya, T | 1 |
| Gottanka, J | 1 |
| Johnson, DH | 1 |
| Lütjen-Drecoll, E | 1 |
| Parek, JG | 1 |
| Raviv, T | 1 |
| Speaker, MG | 1 |
| Hitchings, R | 1 |
| Stewart, WC | 1 |
| Halper, LK | 1 |
| Johnson-Pratt, L | 1 |
| Polis, A | 1 |
| Hartenbaum, D | 1 |
| Fry, LL | 1 |
| West, J | 1 |
| Burke, J | 1 |
| Cunliffe, I | 1 |
| Longstaff, S | 1 |
| Rohrschneider, K | 1 |
| Koch, HR | 1 |
| Heike, M | 1 |
| Marmor, MF | 1 |
| De Marchi, S | 1 |
| Cecchin, E | 1 |
| Tesio, F | 1 |
| Rossert, J | 1 |
| Rondeau, E | 1 |
| Jondeau, G | 1 |
| Ronco, P | 1 |
| Mougenot, B | 1 |
| Kanfer, A | 1 |
| Sraer, JD | 1 |
| Stilma, JS | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Efficacy and Safety of Aqueous Humour Release (Burping) Performed at the Slit-lamp to Treat Acute Intraocular Pressure (IOP) Spikes Post-cataract Surgery[NCT03500809] | 20 participants (Anticipated) | Interventional | 2018-08-12 | Not yet recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 reviews available for acetazolamide and Glaucoma, Suspect
| Article | Year |
|---|---|
Electrophysiological tests in evaluation of glaucoma and ocular hypertension treatment--up to date knowledge. A review.
Topics: Acetazolamide; Dose-Response Relationship, Drug; Electroretinography; Glaucoma; Humans; Intraocular | 2013 |
[Ocular hypertension after intravitreal steroid injections: Clinical update as of 2015].
Topics: Acetazolamide; Adrenal Cortex Hormones; Adult; Animals; Child; Delayed-Action Preparations; Dexameth | 2015 |
[Latanoprost topical ophthalmic combinations].
Topics: Acetazolamide; Administration, Topical; Antihypertensive Agents; Brimonidine Tartrate; Dinoprost; Dr | 2004 |
Anesthesia and preoperative and postoperative medications.
Topics: Acetazolamide; Adrenergic beta-Antagonists; Anesthesia, Local; Anesthetics, Local; Anti-Bacterial Ag | 1996 |
30 trials available for acetazolamide and Glaucoma, Suspect
| Article | Year |
|---|---|
Intraocular pressure elevation after cataract surgery and its prevention by oral acetazolamide in eyes with pseudoexfoliation syndrome.
Topics: Acetazolamide; Administration, Oral; Aged; Carbonic Anhydrase Inhibitors; Exfoliation Syndrome; Fema | 2018 |
Comparison of acetazolamide, brimonidine, and anterior chamber paracentesis for ocular hypertension control after initial intravitreal bevacizumab injection: a randomized clinical trial.
Topics: Acetazolamide; Administration, Oral; Administration, Topical; Aged; Angiogenesis Inhibitors; Anterio | 2014 |
Short-term intraocular pressure trends following intravitreal ranibizumab injections for neovascular age-related macular degeneration-the role of oral acetazolamide in protecting glaucoma patients.
Topics: Acetazolamide; Administration, Oral; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, M | 2014 |
Prophylactic Effect of Oral Acetazolamide against Intraocular Pressure Elevation after Cataract Surgery in Eyes with Glaucoma.
Topics: Acetazolamide; Administration, Oral; Adult; Aged; Aged, 80 and over; Carbonic Anhydrase Inhibitors; | 2017 |
Efficacy and safety of preoperative IOP reduction using a preservative-free fixed combination of dorzolamide/timolol eye drops versus oral acetazolamide and dexamethasone eye drops and assessment of the clinical outcome of trabeculectomy in glaucoma.
Topics: Acetazolamide; Aged; Antihypertensive Agents; Dexamethasone; Drug Combinations; Female; Fluorouracil | 2017 |
[Efficacy of prophylactic treatment of intraocular pressure spikes due to intravitreal injections].
Topics: Acetazolamide; Aged; Antibodies, Monoclonal, Humanized; Antihypertensive Agents; Bevacizumab; Brimon | 2012 |
Effects on aqueous flow of dorzolamide combined with either timolol or acetazolamide.
Topics: Acetazolamide; Administration, Oral; Administration, Topical; Adult; Aged; Antihypertensive Agents; | 2004 |
[Impact of prostaglandin-F(2alpha)-analogues and carbonic anhydrase inhibitors on central corneal thickness -- a cross-sectional study on 403 eyes].
Topics: Acetazolamide; Administration, Topical; Adult; Aged; Carbonic Anhydrase Inhibitors; Cloprostenol; Co | 2004 |
Comparative efficacy of acetazolamide and apraclonidine in the control of intraocular pressure following phacoemulsification.
Topics: Acetazolamide; Administration, Oral; Administration, Topical; Adrenergic alpha-Agonists; Aged; Aged, | 2006 |
Effect of antiglaucoma agents on postoperative intraocular pressure after cataract surgery with Viscoat.
Topics: Acetazolamide; Acetylcholine; Administration, Topical; Aged; Aged, 80 and over; Antihypertensive Age | 2007 |
Betaxolol and acetazolamide. Combined ocular hypotensive effect.
Topics: Acetazolamide; Administration, Oral; Adult; Aged; Aqueous Humor; Betaxolol; Clinical Trials as Topic | 1984 |
Effectiveness of apraclonidine and acetazolamide in preventing postoperative intraocular pressure spikes after extracapsular cataract extraction.
Topics: Acetazolamide; Administration, Oral; Administration, Topical; Adrenergic alpha-Agonists; Aged; Catar | 1995 |
Sideport incision paracentesis versus antiglaucoma medication to control postoperative pressure rises after intraocular lens surgery.
Topics: Acetazolamide; Aged; Aqueous Humor; Cataract Extraction; Drainage; Female; Humans; Intraocular Press | 1993 |
[Increased intraocular pressure after cataract extraction--effect of surgical technique, surgical procedure and preventive drug administration. A prospective, randomized double-blind study].
Topics: Acetazolamide; Adrenergic alpha-Agonists; Aged; Aged, 80 and over; Cataract Extraction; Clinical Com | 1995 |
Effect of timolol vs. acetazolamide on sodium hyaluronate-induced rise in intraocular pressure after cataract surgery.
Topics: Acetazolamide; Administration, Oral; Adult; Aged; Aged, 80 and over; Cataract Extraction; Female; Hu | 1994 |
Prophylactic use of acetazolamide to prevent intraocular pressure elevation following Nd-YAG laser posterior capsulotomy.
Topics: Acetazolamide; Administration, Oral; Aged; Aged, 80 and over; Double-Blind Method; Female; Humans; L | 1993 |
Early postoperative intraocular pressure pattern in glaucomatous and nonglaucomatous patients.
Topics: Acetazolamide; Administration, Topical; Adrenergic beta-Antagonists; Aged; Carbonic Anhydrase Inhibi | 1996 |
The effect of prophylactic acetazolamide in patients undergoing extensive retinal detachment repair.
Topics: Acetazolamide; Female; Humans; Intraocular Pressure; Length of Stay; Male; Middle Aged; Ocular Hyper | 1996 |
Comparison of topical timolol gel to oral acetazolamide in the prophylaxis of viscoelastic-induced ocular hypertension after penetrating keratoplasty.
Topics: Acetazolamide; Administration, Oral; Administration, Topical; Adrenergic beta-Antagonists; Carbonic | 1997 |
Additive ocular hypotensive effect of latanoprost and acetazolamide. A short-term study in patients with elevated intraocular pressure.
Topics: Acetazolamide; Administration, Oral; Administration, Topical; Aged; Carbonic Anhydrase Inhibitors; C | 1997 |
Topical 2.0% dorzolamide vs oral acetazolamide for prevention of intraocular pressure rise after neodymium:YAG laser posterior capsulotomy.
Topics: Acetazolamide; Administration, Oral; Administration, Topical; Aged; Aged, 80 and over; Carbonic Anhy | 1997 |
Timolol gel versus acetazolamide in the prophylaxis of ocular hypertension after phacoemulsification.
Topics: Acetazolamide; Adrenergic beta-Antagonists; Carbonic Anhydrase Inhibitors; Delayed-Action Preparatio | 1997 |
Combination of systemic acetazolamide and topical dorzolamide in reducing intraocular pressure and aqueous humor formation.
Topics: Acetazolamide; Administration, Oral; Administration, Topical; Adult; Aqueous Humor; Carbonic Anhydra | 1998 |
A comparison of the effectiveness of dorzolamide and acetazolamide in preventing post-operative intraocular pressure rise following phacoemulsification surgery.
Topics: Acetazolamide; Administration, Oral; Aged; Aged, 80 and over; Carbonic Anhydrase Inhibitors; Female; | 1998 |
Medical control of intraocular pressure after cataract surgery.
Topics: Acetazolamide; Administration, Oral; Administration, Topical; Adrenergic alpha-Agonists; Aged; Carbo | 1998 |
A comparison of the efficacy and tolerability of dorzolamide and acetazolamide as adjunctive therapy to timolol. Oral to Topical CAI Study Group.
Topics: Acetazolamide; Administration, Oral; Administration, Topical; Adrenergic beta-Antagonists; Adult; Ag | 1998 |
Intraoperative acetazolamide in the prevention of intraocular pressure rise after pars plana vitrectomy with fluid-gas exchange.
Topics: Acetazolamide; Ciliary Body; Gases; Humans; Injections, Intravenous; Intraocular Pressure; Intraoper | 1999 |
Tolerability and efficacy of dorzolamide versus acetazolamide added to timolol.
Topics: Acetazolamide; Administration, Oral; Administration, Topical; Adult; Aged; Aged, 80 and over; Carbon | 2002 |
Comparison of the postoperative intraocular pressure with Betagan, Betoptic, Timoptic, Iopidine, Diamox, Pilopine Gel, and Miostat.
Topics: Acetazolamide; Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Antihypertensive Agents; Cata | 1992 |
Prevention of acute postoperative pressure rises in glaucoma patients undergoing cataract extraction with posterior chamber lens implant.
Topics: Acetazolamide; Acetylcholine; Acute Disease; Aged; Aged, 80 and over; Cataract Extraction; Drug Ther | 1992 |
35 other studies available for acetazolamide and Glaucoma, Suspect
| Article | Year |
|---|---|
Topically active carbonic anhydrase inhibitors. 2. Benzo[b]thiophenesulfonamide derivatives with ocular hypotensive activity.
Topics: Animals; Carbonic Anhydrase Inhibitors; Chemical Phenomena; Chemistry; Glaucoma; Guinea Pigs; Intrao | 1989 |
Synthesis and crystallographic analysis of new sulfonamides incorporating NO-donating moieties with potent antiglaucoma action.
Topics: Animals; Carbonic Anhydrase Inhibitors; Crystallography, X-Ray; Disease Models, Animal; Glaucoma; Hu | 2011 |
1,3-Oxazole-based selective picomolar inhibitors of cytosolic human carbonic anhydrase II alleviate ocular hypertension in rabbits: Potency is supported by X-ray crystallography of two leads.
Topics: Animals; Binding Sites; Carbonic Anhydrase II; Carbonic Anhydrase Inhibitors; Crystallography, X-Ray | 2017 |
High rate of conversion from ocular hypertension to glaucoma in subjects with uveitis.
Topics: Acetazolamide; Female; Glaucoma; HLA-B27 Antigen; Humans; Male; Middle Aged; Ocular Hypertension; Uv | 2022 |
Iris metastasis as the initial presentation of metastatic esophageal cancer diagnosed by fine needle aspiration biopsy: A case report.
Topics: Acetazolamide; Administration, Oral; Aged; Anterior Chamber; Biopsy, Fine-Needle; Carbonic Anhydrase | 2021 |
A complex case of haemodialysis induced increased intraocular pressure.
Topics: Acetazolamide; Antihypertensive Agents; Diabetes Mellitus, Type 1; Glaucoma, Neovascular; Humans; In | 2019 |
Acetazolamide-induced bilateral choroidal effusion following insertion of a phakic implantable collamer lens.
Topics: Acetazolamide; Administration, Oral; Adult; Carbonic Anhydrase Inhibitors; Choroid; Choroid Diseases | 2013 |
Urrets- Zavalia Syndrome after glaucoma filtration device implantation.
Topics: Acetazolamide; Aged; Brimonidine Tartrate; Cataract Extraction; Combined Modality Therapy; Drug Resi | 2013 |
Is the 1-day postoperative IOP check needed post uncomplicated phacoemulsification in patients with glaucoma and ocular hypertension?
Topics: Acetazolamide; Adult; Aged; Aged, 80 and over; Carbonic Anhydrase Inhibitors; Cataract; Female; Glau | 2015 |
Urrets-Zavalia syndrome after Descemet membrane endothelial keratoplasty.
Topics: Acetazolamide; Aged; Cataract Extraction; Combined Modality Therapy; Descemet Stripping Endothelial | 2015 |
Pharmacologic Management of Pressure-Induced Stromal Keratopathy after LASIK.
Topics: Acetazolamide; Adult; Anti-Inflammatory Agents, Non-Steroidal; Antihypertensive Agents; Brimonidine | 2016 |
Pupil block following inadvertent back to front implantation of a 5 degrees vaulted posterior chamber intraocular lens.
Topics: Acetazolamide; Aged; Cyclopentolate; Drug Therapy, Combination; Female; Glaucoma; Humans; Intraocula | 2010 |
Aqueous humor dynamics in inbred rhesus monkeys with naturally occurring ocular hypertension.
Topics: Acetazolamide; Animals; Animals, Inbred Strains; Aqueous Humor; Carbonic Anhydrase Inhibitors; Cilia | 2010 |
A case of ocular hypertension complicated by SUNCT syndrome.
Topics: Acetazolamide; Amlodipine; Carbamazepine; Drug Therapy, Combination; Female; Humans; Intraocular Pre | 2010 |
Short-term changes in intraocular pressure after phacoemulsification in glaucoma patients.
Topics: Acetazolamide; Administration, Oral; Aged; Carbonic Anhydrase Inhibitors; Cataract; Glaucoma, Open-A | 2012 |
[The effect of a new diuretic, diamox, on pathological ocular hypertension].
Topics: Acetazolamide; Diuretics; Glaucoma; Hydro-Lyases; Ocular Hypertension | 1954 |
[Effect of diamox on eye hypertension].
Topics: Acetazolamide; Aged; Glaucoma; Humans; Hypertension; Ocular Hypertension | 1957 |
[Medical treatment of acute ocular hypertension].
Topics: Acetazolamide; Eye Diseases; Glucose; Humans; Intraocular Pressure; Ocular Hypertension; Pilocarpine | 1961 |
In vivo confocal microscopic findings of interlamellar stromal keratopathy induced by elevated intraocular pressure.
Topics: Acetazolamide; Adult; Antihypertensive Agents; Corneal Diseases; Corneal Stroma; Drug Therapy, Combi | 2006 |
Intraocular pressure rise after use of Healon 5 during extracapsular cataract surgery.
Topics: Acetazolamide; Aged; Carbonic Anhydrase Inhibitors; Cataract Extraction; Humans; Hyaluronic Acid; In | 2007 |
Methylcellulose, a viscous cushioning material in ophthalmic surgery.
Topics: Acetazolamide; Eye; Humans; Lenses, Intraocular; Methods; Methylcellulose; Ocular Hypertension | 1983 |
Local ocular hypotensive effect of topically applied acetazolamide.
Topics: Acetazolamide; Administration, Topical; Animals; Injections, Intravenous; Intraocular Pressure; Male | 1984 |
Visual field prognosis in early glaucoma. A long-term clinical follow-up.
Topics: Acetazolamide; Follow-Up Studies; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Longitudinal S | 1993 |
First day follow up for routine phacoemulsification?
Topics: Acetazolamide; Humans; Lenses, Intraocular; Ocular Hypertension; Phacoemulsification; Postoperative | 1996 |
Ultrasound biomicroscopic findings in humans with shallow anterior chamber and increased intraocular pressure after the prone provocation test.
Topics: Acetazolamide; Administration, Oral; Aged; Anterior Chamber; Carbonic Anhydrase Inhibitors; Diagnost | 1997 |
Medical control of IOP after cataract surgery.
Topics: Acetazolamide; Adrenergic alpha-Agonists; Carbonic Anhydrase Inhibitors; Clonidine; Drug Therapy, Co | 2000 |
Treatment for subretinal hemorrhage in the macula: pneumatic displacement of hemorrhages.
Topics: Acetazolamide; Aged; Aged, 80 and over; Female; Fundus Oculi; Humans; Injections; Intraocular Pressu | 2000 |
Beta-adrenergic blocker therapy and the trabecular meshwork.
Topics: Acetazolamide; Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Aqueous Humor; Drug Therapy, Co | 2001 |
Grossly false applanation tonometry associated with interface fluid in susceptible LASIK patients.
Topics: Acetazolamide; Adult; Body Fluids; Carbonic Anhydrase Inhibitors; Diagnostic Errors; Humans; Intraoc | 2001 |
Traumatic glaucoma.
Topics: Acetazolamide; Adult; Carbonic Anhydrase Inhibitors; Cataract; Eye Injuries; Glaucoma; Golf; Humans; | 2001 |
[Effects of acetazolamide (Diamox, Glaupax) on tear production].
Topics: Acetazolamide; Aged; Cataract Extraction; Female; Glaucoma; Humans; Intraocular Pressure; Male; Ocul | 1991 |
Recovery of retinal pigment epithelial function after ischemia in the rabbit.
Topics: Acetazolamide; Animals; Choroid; Dark Adaptation; Disease Models, Animal; Electroretinography; Intra | 1991 |
Intraocular pressure changes during hemodialysis: prevention of excessive dialytic rise and development of severe metabolic acidosis following acetazolamide therapy.
Topics: Acetazolamide; Acid-Base Equilibrium; Acidosis; Adult; Aged; Female; Gonioscopy; Humans; Intraocular | 1989 |
Tamm-Horsfall protein accumulation in glomeruli during acetazolamide-induced acute renal failure.
Topics: Acetazolamide; Acute Kidney Injury; Fluorescent Antibody Technique; Humans; Kidney Glomerulus; Male; | 1989 |
Prevention of intra-ocular pressure elevation following laser surgery.
Topics: Acetazolamide; Drug Therapy, Combination; Humans; Laser Therapy; Ocular Hypertension; Timolol | 1986 |